Qiagen (QGEN) Liabilities and Shareholders Equity (2009 - 2026)

Qiagen (QGEN) has 18 years of Liabilities and Shareholders Equity data on file, last reported at $5.8 billion in Q1 2026.

• Quarterly Liabilities and Shareholders Equity rose 4.27% year-over-year to $5.8 billion in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $24.4 billion (up 5.85% YoY) and the FY2025 annual result came in at $6.3 billion, up 10.4% from the prior year.
• Liabilities and Shareholders Equity fell to $5.8 billion in Q1 2026 per QGEN's latest filing, from $6.3 billion in the prior quarter.
• The five-year high for Liabilities and Shareholders Equity was $6.6 billion in Q3 2025, with the low at $5.5 billion in Q1 2025.
• Average Liabilities and Shareholders Equity over 5 years is $6.1 billion, with a median of $6.2 billion recorded in 2022.
• Year-over-year, Liabilities and Shareholders Equity declined 12.02% in 2024 and gained 10.4% in 2025.
• Qiagen's Liabilities and Shareholders Equity stood at $6.3 billion in 2022, then decreased by 2.74% to $6.1 billion in 2023, then dropped by 6.96% to $5.7 billion in 2024, then gained by 10.4% to $6.3 billion in 2025, then slipped by 7.95% to $5.8 billion in 2026.
• Business Quant data shows QGEN's Liabilities and Shareholders Equity at $5.8 billion in Q1 2026, $6.3 billion in Q4 2025, and $6.6 billion in Q3 2025.